Anti-cancer drug shows early promise in pulmonary hypertension
14th Nov 2006, 22:41 GMT
A drug used to treat kidney cancer can prevent the development of pulmonary hypertension in rodents. There is no curative therapy for this condition.
Anti-cancer drug shows early promise in pulmonary hypertension related news:
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- Pulmonary Hypertension and COPD — Medscape Pulmonary Medicine Headlines
- Drug That Interrupts A Key Stage Of Cell Division Shows Promise For Advanced Solid Tumors — Health News from Medical News Today
- Drug That Interrupts A Key Stage Of Cell Division Shows Promise In Patients With Advanced Solid Tumours — Health News from Medical News Today
- Health Tip: Understanding Pulmonary Hypertension — MedicineNet Senior Health General
- Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- Novel Vaccine Shows Promise Against Early-stage Breast Cancer — ScienceDaily Headlines
- Patients Respond Well To Higher Doses Of An Anti-cancer Drug - Limited Side Effects And Evidence Of Clinical Activity — Health News from Medical News Today
- Arqule Early Cancer Study Shows Progress — Bio-Technology News from StratCenter.com
- Clinical Trial Findings Show Significant Reduction in Blood Pressure With CVRx(R) Rheos(TM) Baroreflex Hypertension Therapy(TM) System — RedOrbit News - Health
Latest news from EurekAlert! - Breaking News:
- Scientists capture nanoscale images with short and intense X-ray laser
- Mayo researchers offer evidence people with psoriasis greater risk for developing heart disease
- Mayo Clinic information about accelerated aging among people with rheumatoid arthritis
- ESSP launches project on the effects of global environmental change on human health
- Health inequalities are a growing problem worldwide
- HIV/AIDS linked to extensively drug resistant TB
- Higher death rate for heart attack patients with additional non-cardiac conditions
- Hormone linked to brain's cravings for food and other energy sources
- Key to acute lung injury lies in Ang2 protein
- Propane fuel cell passes muster at Exit Glacier Nature Center